Culturally tailored computer education program for African-American patients with chronic kidney disease
A Pilot to Develop and Test an Interactive Computer-adaptive Chronic Kidney Disease Education Program for Hospitalized African American Patients (I-C-CKD)
This study tests a special computer education program for African-American patients with advanced chronic kidney disease to see if it helps them understand their condition and treatment options better than regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06364358 on ClinicalTrials.gov |
What this trial studies
This pilot clinical trial evaluates a culturally tailored computerized education program designed for hospitalized African-American patients with advanced chronic kidney disease (CKD). The study compares the effectiveness of this program, known as computerized adaptive education (CAE), against standard care in improving patients' knowledge about CKD self-care and renal replacement therapy (RRT) options. It also assesses whether CAE increases patients' intent to engage in CKD self-care practices and prepare for RRT. Outcomes are measured using various surveys to gauge knowledge and patient activation.
Who should consider this trial
Good fit: Ideal candidates are African-American inpatients aged 18-70 with an estimated glomerular filtration rate (eGFR) less than 45.
Not a fit: Patients who do not self-identify as African American, are unable to consent, or have acute kidney injury will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance patient understanding and engagement in managing chronic kidney disease, leading to better health outcomes.
How similar studies have performed: Other studies have shown success with culturally tailored educational interventions, suggesting a positive outlook for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * African-American inpatients * Ages 18-70 * estimated glomerular filtration rate (eGFR)\<45 * Enrolled in the Hospitalist Project Exclusion Criteria: * Does not self-identify as African American * Not able to consent * Unable to speak English * eGFR \<45 due to acute kidney injury * In Intensive Care Unit * has had a transplant * currently on dialysis
Where this trial is running
Chicago, Illinois
- University of Chicago Medical Center — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Milda Saunders, MD — Associate Professor of Medicine
- Study coordinator: Milda Saunders, MD
- Email: msaunder@bsd.uchicago.edu
- Phone: 7737025941
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.